» Articles » PMID: 25072194

Guillain-Barré and Miller Fisher Syndromes--new Diagnostic Classification

Overview
Journal Nat Rev Neurol
Specialty Neurology
Date 2014 Jul 30
PMID 25072194
Citations 193
Authors
Affiliations
Soon will be listed here.
Abstract

Guillain-Barré syndrome (GBS) and its variant, Miller Fisher syndrome (MFS), exist as several clinical subtypes with different neurological features and presentations. Although the typical clinical features of GBS and MFS are well recognized, current classification systems do not comprehensively describe the full spectrum of either syndrome. In this Perspectives article, GBS and MFS are classified on the basis of current understanding of the common pathophysiological profiles of each disease phenotype. GBS is subclassified into classic and localized forms (for example, pharyngeal-cervical-brachial weakness and bifacial weakness with paraesthesias), and MFS is divided into incomplete (for example, acute ophthalmoparesis, acute ataxic neuropathy) and CNS subtypes (Bickerstaff brainstem encephalitis). Diagnostic criteria based on clinical characteristics are suggested for each condition. We believe this approach to be more inclusive than existing systems, and argue that it could facilitate early clinical diagnosis and initiation of appropriate immunotherapy.

Citing Articles

Case report: Plasma exchange as a therapy for Miller-Fisher syndrome.

Guan D, Shan Y, Zhang H Front Immunol. 2025; 16:1460034.

PMID: 40040715 PMC: 11876028. DOI: 10.3389/fimmu.2025.1460034.


A Rare Case of Bickerstaff Encephalitis in Childhood: A Case Report.

Giaccari L, Mastria D, Barbieri R, De Maglio R, Madaro F, Paiano G Neurol Int. 2025; 17(2).

PMID: 39997655 PMC: 11858127. DOI: 10.3390/neurolint17020024.


A 73-Year-Old Man Presenting with Shoulder Muscle Pain and a Diagnosis of Guillain-Barré Syndrome.

Cheng Y, Wu B, Guo Y, Huang J Am J Case Rep. 2025; 26:e945539.

PMID: 39923125 PMC: 11818942. DOI: 10.12659/AJCR.945539.


Response to Letter to the Editor: Clarifying Diagnostic Criteria and the Role of Serum Neurofilament Light Chain in Immune-Mediated Neuropathies.

Afzali A, Hemmer B Eur J Neurol. 2025; 32(2):e70072.

PMID: 39905705 PMC: 11794235. DOI: 10.1111/ene.70072.


A Case Report of Anti-GD3 Antibody Positive Incomplete Miller-Fisher Syndrome With Pyramidal Tract Symptoms.

Li Z, Li J, Liu L, Chen J, Mao X, Yang J Clin Case Rep. 2025; 13(2):e70144.

PMID: 39895850 PMC: 11785465. DOI: 10.1002/ccr3.70144.


References
1.
Ropper A . Unusual clinical variants and signs in Guillain-Barré syndrome. Arch Neurol. 1986; 43(11):1150-2. DOI: 10.1001/archneur.1986.00520110044012. View

2.
. Research criteria for diagnosis of chronic inflammatory demyelinating polyneuropathy (CIDP). Report from an Ad Hoc Subcommittee of the American Academy of Neurology AIDS Task Force. Neurology. 1991; 41(5):617-8. View

3.
Ropper A . The Guillain-Barré syndrome. N Engl J Med. 1992; 326(17):1130-6. DOI: 10.1056/NEJM199204233261706. View

4.
Jackson C, Barohn R, Mendell J . Acute paralytic syndrome in three American men. Comparison with Chinese cases. Arch Neurol. 1993; 50(7):732-5. DOI: 10.1001/archneur.1993.00540070050014. View

5.
Miura Y, Susuki K, Yuki N, Ayabe M, Shoji H . Guillain-barré syndrome presenting pharyngeal-cervical-brachial weakness in the recovery phase. Eur Neurol. 2002; 48(1):53-4. DOI: 10.1159/000064963. View